[go: up one dir, main page]

HUP0003116A2 - Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok - Google Patents

Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok

Info

Publication number
HUP0003116A2
HUP0003116A2 HU0003116A HUP0003116A HUP0003116A2 HU P0003116 A2 HUP0003116 A2 HU P0003116A2 HU 0003116 A HU0003116 A HU 0003116A HU P0003116 A HUP0003116 A HU P0003116A HU P0003116 A2 HUP0003116 A2 HU P0003116A2
Authority
HU
Hungary
Prior art keywords
amyloid peptide
proteins
betha
same
subject
Prior art date
Application number
HU0003116A
Other languages
English (en)
Inventor
Jonathan Adam Bard
Jack Steven Jacobsen
Eileen Marie Kajkowski
Bradley Alton Ozenberger
Stephen Glenn Walker
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of HUP0003116A2 publication Critical patent/HUP0003116A2/hu
Publication of HUP0003116A3 publication Critical patent/HUP0003116A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Atalálmány tárgyát b-amiloidpeptidhez kötődő új polinukleotidok és azáltaluk kódolt fehérjék, a fehérjéket vagy részeiket kódoló fúziósfehérjék és a hozzájuk kötődő antitestek képezik, továbbá eljárásokezek előállítására. Atalálmány tárgyát képezik továbbá a találmányszerinti polinukleotidokkal transzformált gazdasejtek és az azokattartalmazó transzgenikus állatok. Atalálmány tárgyát képezik továbbáeljárások a fehérjék és a nukleotidok terápiás, diagnosztikai éskutatási célokra való alkalmazására. A találmány szerinti megoldásAlzheimer-kór kezelésében, diagnózisában, továbbá az ezzel a kórralkapcsolatos kutatások területén alkalmazható. Ó
HU0003116A 1997-04-16 1998-04-14 Betha-amyloid peptide-binding proteins and polynucleotides encoding the same HUP0003116A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6458397P 1997-04-16 1997-04-16

Publications (2)

Publication Number Publication Date
HUP0003116A2 true HUP0003116A2 (hu) 2001-01-29
HUP0003116A3 HUP0003116A3 (en) 2003-03-28

Family

ID=22056941

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003116A HUP0003116A3 (en) 1997-04-16 1998-04-14 Betha-amyloid peptide-binding proteins and polynucleotides encoding the same

Country Status (18)

Country Link
EP (1) EP0975753A2 (hu)
JP (3) JP2001523093A (hu)
KR (1) KR20010006393A (hu)
CN (2) CN1690203A (hu)
AU (1) AU740445B2 (hu)
BR (1) BR9808562A (hu)
CA (1) CA2286484A1 (hu)
EA (1) EA004256B1 (hu)
EE (1) EE9900482A (hu)
GE (1) GEP20043386B (hu)
HU (1) HUP0003116A3 (hu)
ID (1) ID24914A (hu)
IL (3) IL132236A0 (hu)
NO (1) NO995062L (hu)
NZ (1) NZ500216A (hu)
SK (1) SK143299A3 (hu)
UA (1) UA72875C2 (hu)
WO (1) WO1998046636A2 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en) * 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
AU769307B2 (en) * 1998-10-13 2004-01-22 Wyeth G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same
US6455082B1 (en) * 1999-04-26 2002-09-24 Nestec S.A. Shelf-stable calcium fortified milk and dairy products
WO2001029225A1 (en) * 1999-10-21 2001-04-26 Panorama Research, Inc. A general method for optimizing the expression of heterologous proteins
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7807171B2 (en) 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US9289488B2 (en) 2010-08-12 2016-03-22 Ac Immune Sa Vaccine engineering
CA2813833C (en) 2010-10-26 2020-09-22 Ac Immune S.A. Liposome-based construct comprising a peptide modified through hydrophobic moieties
CN102060912B (zh) * 2010-11-22 2012-11-14 清华大学 淀粉样蛋白寡聚体构象型抗原表位多肽及其应用
CN111320678B (zh) * 2020-03-09 2023-06-09 安亭生物有限责任公司 抗菌肽突变体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE169673T1 (de) * 1986-11-17 1998-08-15 Scios Inc Rekombiniertes alzheimer amyloid-protein
IL115743A0 (en) * 1994-10-28 1996-01-19 American Nat Red Cross A mammal with cells containing a transgene and its production
US5786180A (en) * 1995-02-14 1998-07-28 Bayer Corporation Monoclonal antibody 369.2B specific for β A4 peptide

Also Published As

Publication number Publication date
GEP20043386B (en) 2004-02-10
EE9900482A (hu) 2000-06-15
IL179047A0 (en) 2007-03-08
IL132236A (en) 2007-03-08
KR20010006393A (ko) 2001-01-26
CA2286484A1 (en) 1998-10-22
HUP0003116A3 (en) 2003-03-28
AU740445B2 (en) 2001-11-01
AU7115698A (en) 1998-11-11
BR9808562A (pt) 2000-05-23
JP2008104465A (ja) 2008-05-08
IL132236A0 (en) 2001-03-19
EA199900941A1 (ru) 2000-06-26
WO1998046636A2 (en) 1998-10-22
ID24914A (id) 2000-08-31
EP0975753A2 (en) 2000-02-02
SK143299A3 (en) 2000-09-12
CN1196785C (zh) 2005-04-13
CN1690203A (zh) 2005-11-02
JP2008253275A (ja) 2008-10-23
EA004256B1 (ru) 2004-02-26
NO995062L (no) 1999-12-14
NO995062D0 (no) 1999-10-15
CN1268973A (zh) 2000-10-04
UA72875C2 (uk) 2005-05-16
JP2001523093A (ja) 2001-11-20
WO1998046636A3 (en) 1999-01-28
NZ500216A (en) 2001-06-29

Similar Documents

Publication Publication Date Title
ES2278463T3 (es) Metodo para reducir la inmunogenicidad de proteinas.
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE69431834D1 (de) Für den vorläufer des für die tumorabstossung verantwortlichen antigens mage-3 kodierendes, isoliertes nukleinsäuremolekül und seine verwendung
DE69922261D1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
DE60140218D1 (de) Expressionsvektor für tierische zellen
DK0751992T3 (da) Karendotelvækstfaktor 2
DK0910647T3 (da) Human DNase i hyperaktive varianter
DE69534402D1 (de) Apoptose-proteasen 3 und 4, ähnlich dem umwandlungsenzym für interleukin-1beta
HUP0003116A2 (hu) Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok
DK43890D0 (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
CY1109868T1 (el) Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
NZ531570A (en) DNA sequences for human angiogenesis genes
HUP0102479A2 (hu) Neisseria meningitidis-ből származó BASBO29-polinukleotid(ok) és polipeptidek
SG121733A1 (en) Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
EP1270588A4 (en) NEW COLLAGEN-LIKE PROTEIN CLAC, ITS PRECURSORS AND GENES CODING THEREFOR
BR0007816A (pt) Fator de estimulação óssea
ATE278011T1 (de) Human dnase ii
WO2002088378A3 (en) 66784, a novel human potassium channel and uses therefor
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
ATE109509T1 (de) Anticoagulatorisches protein pp4-x, seine herstellung und verwendung.
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
ATE460673T1 (de) Screeningverfahren zum identifizieren protektiver substanzen für die behandlung neurodegenerativer und/oder ischämischer erkrankungen
HUP0203689A2 (hu) Interleukin-1 receptor antagonistaszerű molekulák és ezek használata

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees
HA9A Change in inventorship